Axonics Inc (AXNX)
66.92
-0.13
(-0.19%)
USD |
NASDAQ |
Apr 19, 16:00
66.92
0.00 (0.00%)
After-Hours: 19:51
Axonics Cash from Investing (TTM): -116.90M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -116.90M |
September 30, 2023 | -89.01M |
June 30, 2023 | -177.36M |
March 31, 2023 | -119.37M |
December 31, 2022 | -120.35M |
September 30, 2022 | -111.41M |
June 30, 2022 | -12.69M |
March 31, 2022 | -2.429M |
December 31, 2021 | -143.00M |
September 30, 2021 | -142.94M |
June 30, 2021 | -142.90M |
Date | Value |
---|---|
March 31, 2021 | -143.09M |
December 31, 2020 | 9.654M |
September 30, 2020 | 23.02M |
June 30, 2020 | 41.12M |
March 31, 2020 | 53.12M |
December 31, 2019 | 45.29M |
September 30, 2019 | -15.17M |
June 30, 2019 | -29.11M |
March 31, 2019 | -55.84M |
December 31, 2018 | -60.05M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-177.36M
Minimum
Jun 2023
53.12M
Maximum
Mar 2020
-62.82M
Average
-89.01M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Boston Scientific Corp | -2.574B |
Inspire Medical Systems Inc | -294.82M |
Stereotaxis Inc | 19.76M |
Electromed Inc | -1.219M |
Myomo Inc | -2.030M |